Panacea Global Inc Stock

Panacea Global, Inc. is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. The Company's product is a blood test that can measure the blood level of Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH). Its HAAH (a cancer biomarker) is an enzyme, which is over expressed in cancer cells. This test is recommended for men and women over 50 years of age with a history of smoking cigarettes. Its HAAH Blood Test can help the early diagnosis of prostate cancer. Its HAAH Blood Test provides the physician with additional information about the likelihood that a man with an abnormally high prostate-specific antigen (PSA) value, with or without an abnormal digital rectal examination (DRE), may have prostate cancer. Its HAAH Blood Test provides information to differentiate prostate cancer from benign conditions and to help guide patient management.